To determine current practice patterns of obtaining informed consent for infertility treatment by reproductive endocrinologists and to assess changes in response to reports of an association between ovulation induction and ovarian cancer.
Board-certified reproductive endocrinologists (n=575) were surveyed by mail regarding how they informed patients and obtained consent for infertility treatments and how their practices had been influenced by studies suggesting a link between ovulation induction and ovarian cancer.
Data were analyzed using X2 and logistic regression analyses.
The return rate was 62.1% (357 of 575 surveys).
Most respondents (92%) used discussions with physicians to inform their patients of risks and benefits of all infertility treatments.
Additional means, such as audiovisual aids, were used significantly more often for assisted reproductive technologies (including intracytoplasmic sperm injection and use of donated eggs) than for less invasive therapies (31-43% versus 4-11%, P<. 001).
Most physicians (46-66%) used verbal consent alone for hysterosalpingogram, intrauterine insemination, and ovulation induction.
Formal written consent was used significantly more often for the various assisted reproductive technologies than for hysterosalpingogram, intrauterine insemination, or ovulation induction (94-95% versus 26-44%). (...)
Mots-clés Pascal : Fécondation in vitro transfert embryon, Stérilité, Consentement éclairé, Pratique professionnelle, Médecin, Traitement, Homme, Etats Unis, Amérique du Nord, Amérique, Procréation assistée, Personnel sanitaire
Mots-clés Pascal anglais : In vitro fertilization embryo transfer, Sterility, Informed consent, Professional practice, Physician, Treatment, Human, United States, North America, America, Assisted procreation, Health staff
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 99-0131473
Code Inist : 002B20A04. Création : 16/11/1999.